-
D101734-25mgDonepezil hydrochloride monohydrate.
-
D334301-100mgDoxazosin is an α-1 adrenergic receptor blocker that inhibits the binding of norepinephrine (released from sympathetic nerve terminals) to the α-1 receptors on the membrane of vascular smooth muscle cells.
-
D334301-25mgDoxazosin is an α-1 adrenergic receptor blocker that inhibits the binding of norepinephrine (released from sympathetic nerve terminals) to the α-1 receptors on the membrane of vascular smooth muscle cells.
-
D155442-250mgDrospirenone is a synthetic progestin that is an analog to spironolactone.
-
D155442-50mgDrospirenone is a synthetic progestin that is an analog to spironolactone.
-
D342246-100mgDuloxetine is an ST and SLC6A2 inhibitor (serotonin-norepinephrine reuptake inhibitor/SNRI).
-
D342246-10mgDuloxetine is an ST and SLC6A2 inhibitor (serotonin-norepinephrine reuptake inhibitor/SNRI).
-
D342246-50mgDuloxetine is an ST and SLC6A2 inhibitor (serotonin-norepinephrine reuptake inhibitor/SNRI).
-
D342246-5mgDuloxetine is an ST and SLC6A2 inhibitor (serotonin-norepinephrine reuptake inhibitor/SNRI).
-
I126464-100mgDuvelisib (IPI-145, INK1197) is a novel and selective PI3K δ/γ inhibitor with Ki and IC50 of 23 pM/243 pM and 1 nM/50 nM in cell-free assays, highly selective for PI3K δ/γ than other protein kinases.
-
I126464-10mgDuvelisib (IPI-145, INK1197) is a novel and selective PI3K δ/γ inhibitor with Ki and IC50 of 23 pM/243 pM and 1 nM/50 nM in cell-free assays, highly selective for PI3K δ/γ than other protein kinases.
-
I126464-1gDuvelisib (IPI-145, INK1197) is a novel and selective PI3K δ/γ inhibitor with Ki and IC50 of 23 pM/243 pM and 1 nM/50 nM in cell-free assays, highly selective for PI3K δ/γ than other protein kinases.